-
Thematic Analysis
NewCybersecurity in Automotive – Thematic Intelligence
This report explains the Cybersecurity landscape across the automotive sector. It includes case studies, alternative datasets, value chains, sector scorecards, and an impact assessment. This report is useful to those wishing to understand how cybersecurity can be used across enterprise and consumer uses. We are entering the Code War era, where every digital device, no matter how small, can be weaponized through its unique code. Cybersecurity in vehicles has to be extensive, defending both the frontend and backend of vehicle...
-
Sector Analysis
Automotive Autonomous Driving Systems Market Trends, Sector Overview and Forecast to 2028
Automotive Autonomous Driving Systems Market Report Overview The automotive autonomous driving systems market size was 212.5 million units in 2023. The market will grow at a CAGR of more than 5% during 2023-2028. Improving road safety is one of the primary drivers of autonomous driving systems. In 2023, Asia-Pacific accounted for a significant share of the market. Automotive Autonomous Driving Systems Market Outlook, 2023-2028 (Million Units) Buy the Full Report for More Insights into the Automotive Autonomous Driving Systems Market...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Bone Metastasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Bone Metastasis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Bone Metastasis Drug Details: Denosumab (Jubbonti, Wyost),...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Post Menopausal Osteoporosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Post Menopausal Osteoporosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Post Menopausal Osteoporosis Drug Details: denosumab biosimilar...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Humoral Hypercalcemia of Malignancy Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Denosumab Biosimilar in Giant Cell Tumor Of Bone
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Denosumab Biosimilar in Giant Cell Tumor Of Bone report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Denosumab Biosimilar in Giant Cell Tumor Of...
-
Product Insights
GP Wind Jangi Wind Farm
GP Wind Jangi Wind Farm is an Onshore Wind project located in Gujarat, India. The project is owned and developed by GP Wind (Jangi) Private Limited. The project came online in 2011. Empower your strategies with our GP Wind Jangi Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
GP Joule Euerwang Solar PV Park
GP Joule Euerwang Solar PV Park is a solar PV project located in Bavaria, Germany. The project is owned and developed by GP Joule GmbH. The project came online in 2017. Empower your strategies with our GP Joule Euerwang Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vusolimogene Oderparepvec in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vusolimogene Oderparepvec in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vusolimogene Oderparepvec in Metastatic Melanoma Drug Details: RP-1 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vusolimogene Oderparepvec in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vusolimogene Oderparepvec in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vusolimogene Oderparepvec in Non-Small Cell Lung Cancer Drug Details:...